Trial Profile
A study evaluating efficacy of treatment of botulinum toxin in patients with chronic migraine as per PREEMPT protocol.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 04 Jul 2017 New trial record
- 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society